October 1, 2015 | The American venture capital firm Third Rock Ventures, Len Blavatnik’s Access Industries and a daughter company of Clal Biotechnology will invest $55 million in Neon Therapeutics. The investment will reportedly be used to help Neon Therapeutics complete its cancer immunotherapy. Clal Biotechnoloigy was founded in 1998 and is based out of Ramat Gan, Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments